https://www.selleckchem.com/pr....oducts/pclx-001-ddd8
The aim of this pilot clinical study is to evaluate the safety and efficacy of the ™ sirolimus-coated balloon (M.A. MedAlliance SA, Nyon, Switzerland) for improving the patency of failing arterio-venous fistulas (AVF) in hemodialysis patients. We also present herein a pre-clinical pharmacokinetic and safety evaluation of Selution™ to justify its first use in hemodialysis patients for endovascular access salvage. This is an investigator-initiated prospective single-center, non-blinded single-arm trial. Forty patients with clini
Like
Comment
Share
